AAVAIL HD
Live / Applied — First extension granted (statement of use) (as of 09 Feb 2026)
What this means for you
Not registered yet, but its 09 Oct 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98792819
- Mark type
- Stylized text
- Filed
- 09 Oct 2024
- Published for opposition
- 10 Jun 2025
- Attorney of record
- Susan A. Smith
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for others in the field of Huntington's disease; providing medical research information in the field of clinical trials in relation to Huntington's disease; medical and scientific research in the field of Huntington's disease
Owner
- Spark Therapeutics, Inc., Philadelphia, PA, US
- Spark Therapeutics, Inc., Philadelphia, PA, US
Prosecution history
- 09 Feb 2026 — SOU EXTENSION 1 GRANTED
- 09 Feb 2026 — SOU EXTENSION 1 FILED
- 09 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Jun 2025 — PUBLISHED FOR OPPOSITION
- 04 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 May 2025 — EXAMINER'S AMENDMENT ENTERED
- 07 May 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 07 May 2025 — EXAMINERS AMENDMENT E-MAILED
- 07 May 2025 — EXAMINERS AMENDMENT -WRITTEN
- 28 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Apr 2025 — NON-FINAL ACTION E-MAILED
- 28 Apr 2025 — NON-FINAL ACTION WRITTEN